Florida Senate
-
2025
CS for SB 1360
By
Senator Leek
the Committee on Criminal Justice; and Senator Leek
7-00152A-25 20251360__591-02560-25 20251360c1
1 A bill to be entitled
2 An act relating to controlled substances; amending s.
3 893.03, F.S.; excepting from the Schedule I controlled
4 substance xylazine drug products approved by the
5 United States Food and Drug Administration labeledfor forcertain
6 use; amending s. 893.13, F.S.; providing criminal
7 penalties and requiring a mandatory minimum term of
8 imprisonment if a person sells, manufactures, or
9 delivers or possesses with intent to sell,
610 and prescribedmanufacture, or dispenseddeliver by veterinariansxylazine; addingamending s. 893.135,
11 F.S.; creating the offense of trafficking in xylazine;
12 providing criminal penalties and requiring a mandatory
13 minimum term of imprisonment and fines based on the
714 xylazinequantity asof a Schedule IIIthe controlled substance; involved in the
15 offense; providing an effective date.
16
17 Be It Enacted by the Legislature of the State of Florida:
18
19 Section 1. Paragraph (c) of subsection (1) of section
20 893.03, Florida Statutes, is amended to read:
821 excepting893.03 Standards fromand theschedules.—The Schedulesubstances III controlled substanceenumerated
9 xylazine specified drug products approved by the
10 United States Food and Drug Administration; defining
11 the term “person”; amending s. 893.13, F.S.; providing
12 criminal penalties and requiring a mandatory minimum
13 term of imprisonment if a person sells, manufactures,
14 or delivers or possesses with intent to sell,
15 manufacture, or deliver xylazine; amending s. 893.135,
16 F.S.; creating the offense of trafficking in xylazine;
17 providing criminal penalties and requiring a mandatory
18 minimum term of imprisonment and fines based on the
19 quantity of the controlled substance involved in the
20 offense; providing an effective date.
21
22 Be It Enacted by the Legislature of the State of Florida:
23
24 Section 1. Paragraph (c) of subsection (1) and paragraph
25 (a) of subsection (3) of section 893.03, Florida Statutes, are
26 amended to read:
27 893.03 Standards and schedules.—The substances enumerated
2822 in this section are controlled by this chapter. The controlled
2923 substances listed or to be listed in Schedules I, II, III, IV,
3024 and V are included by whatever official, common, usual,
3125 chemical, trade name, or class designated. The provisions of
3226 this section shall not be construed to include within any of the
3327 schedules contained in this section any excluded drugs listed
3428 within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
3529 Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
3630 Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
3731 Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
3832 Anabolic Steroid Products.”
3933 (1) SCHEDULE I.—A substance in Schedule I has a high
4034 potential for abuse and has no currently accepted medical use in
4135 treatment in the United States and in its use under medical
4236 supervision does not meet accepted safety standards. The
4337 following substances are controlled in Schedule I:
4438 (c) Unless specifically excepted or unless listed in
4539 another schedule, any material, compound, mixture, or
4640 preparation that contains any quantity of the following
4741 hallucinogenic substances or that contains any of their salts,
4842 isomers, including optical, positional, or geometric isomers,
4943 homologues, nitrogen-heterocyclic analogs, esters, ethers, and
5044 salts of isomers, homologues, nitrogen-heterocyclic analogs,
5145 esters, or ethers, if the existence of such salts, isomers, and
5246 salts of isomers is possible within the specific chemical
5347 designation or class description:
5448 1. Alpha-Ethyltryptamine.
5549 2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2
5650 oxazoline).
5751 3. Aminorex (2-Amino-5-phenyl-2-oxazoline).
5852 4. DOB (4-Bromo-2,5-dimethoxyamphetamine).
5953 5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
6054 6. Bufotenine.
6155 7. Cannabis.
6256 8. Cathinone.
6357 9. DET (Diethyltryptamine).
6458 10. 2,5-Dimethoxyamphetamine.
6559 11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).
6660 12. DMT (Dimethyltryptamine).
6761 13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine
6862 analog of phencyclidine).
6963 14. JB-318 (N-Ethyl-3-piperidyl benzilate).
7064 15. N-Ethylamphetamine.
7165 16. Fenethylline.
7266 17. 3,4-Methylenedioxy-N-hydroxyamphetamine.
7367 18. Ibogaine.
7468 19. LSD (Lysergic acid diethylamide).
7569 20. Mescaline.
7670 21. Methcathinone.
7771 22. 5-Methoxy-3,4-methylenedioxyamphetamine.
7872 23. PMA (4-Methoxyamphetamine).
7973 24. PMMA (4-Methoxymethamphetamine).
8074 25. DOM (4-Methyl-2,5-dimethoxyamphetamine).
8175 26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
8276 27. MDA (3,4-Methylenedioxyamphetamine).
8377 28. JB-336 (N-Methyl-3-piperidyl benzilate).
8478 29. N,N-Dimethylamphetamine.
8579 30. Parahexyl.
8680 31. Peyote.
8781 32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
8882 analog of phencyclidine).
8983 33. Psilocybin.
9084 34. Psilocyn.
9185 35.
Salvia divinorum
, except for any drug product approved
9286 by the United States Food and Drug Administration which contains
93
87
Salvia divinorum
or its isomers, esters, ethers, salts, and
9488 salts of isomers, esters, and ethers, if the existence of such
9589 isomers, esters, ethers, and salts is possible within the
9690 specific chemical designation.
9791 36. Salvinorin A, except for any drug product approved by
9892 the United States Food and Drug Administration which contains
9993 Salvinorin A or its isomers, esters, ethers, salts, and salts of
10094 isomers, esters, and ethers, if the existence of such isomers,
10195 esters, ethers, and salts is possible within the specific
10296 chemical designation.
10397 37. Xylazine
,
, except for anya xylazine animal drug product approved by the
98
approved by the United States Food and Drug Administration, the
99
use of which conforms to the approved application or is
104100
United States Food and Drug Administration which contains
authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,
105101
xylazine or a compounded form of xylazine labeled for veterinary
importation, distribution, prescribing, or sale of xylazine for
106102
use and prescribed or dispensed by a veterinarian licensed under
107
chapter
474
human use is not subject to this exception
.
108103 38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
109104 (Thiophene analog of phencyclidine).
110105 39. 3,4,5-Trimethoxyamphetamine.
111106 40. Methylone (3,4-Methylenedioxymethcathinone).
112107 41. MDPV (3,4-Methylenedioxypyrovalerone).
113108 42. Methylmethcathinone.
114109 43. Methoxymethcathinone.
115110 44. Fluoromethcathinone.
116111 45. Methylethcathinone.
117112 46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
118113 yl)phenol) and its dimethyloctyl (C8) homologue.
119114 47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2
120115 methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].
121116 48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
122117 49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
123118 50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
124119 naphthoyl)indole).
125120 51. BZP (Benzylpiperazine).
126121 52. Fluorophenylpiperazine.
127122 53. Methylphenylpiperazine.
128123 54. Chlorophenylpiperazine.
129124 55. Methoxyphenylpiperazine.
130125 56. DBZP (1,4-Dibenzylpiperazine).
131126 57. TFMPP (Trifluoromethylphenylpiperazine).
132127 58. MBDB (Methylbenzodioxolylbutanamine) or (3,4
133128 Methylenedioxy-N-methylbutanamine).
134129 59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
135130 60. 5-Hydroxy-N-methyltryptamine.
136131 61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
137132 62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
138133 63. Methyltryptamine.
139134 64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
140135 65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
141136 66. Tyramine (4-Hydroxyphenethylamine).
142137 67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
143138 68. DiPT (N,N-Diisopropyltryptamine).
144139 69. DPT (N,N-Dipropyltryptamine).
145140 70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
146141 71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
147142 72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
148143 73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
149144 74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
150145 75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
151146 76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
152147 77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
153148 78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
154149 79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
155150 80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
156151 81. Butylone (3,4-Methylenedioxy-alpha
157152 methylaminobutyrophenone).
158153 82. Ethcathinone.
159154 83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
160155 84. Naphyrone (Naphthylpyrovalerone).
161156 85. Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).
162157 86. 3,4-Methylenedioxy-N,N-diethylcathinone.
163158 87. 3,4-Methylenedioxy-propiophenone.
164159 88. 3,4-Methylenedioxy-alpha-bromopropiophenone.
165160 89. 3,4-Methylenedioxy-propiophenone-2-oxime.
166161 90. 3,4-Methylenedioxy-N-acetylcathinone.
167162 91. 3,4-Methylenedioxy-N-acetylmethcathinone.
168163 92. 3,4-Methylenedioxy-N-acetylethcathinone.
169164 93. Bromomethcathinone.
170165 94. Buphedrone (alpha-Methylamino-butyrophenone).
171166 95. Eutylone (3,4-Methylenedioxy-alpha
172167 ethylaminobutyrophenone).
173168 96. Dimethylcathinone.
174169 97. Dimethylmethcathinone.
175170 98. Pentylone (3,4-Methylenedioxy-alpha
176171 methylaminovalerophenone).
177172 99. MDPPP (3,4-Methylenedioxy-alpha
178173 pyrrolidinopropiophenone).
179174 100. MDPBP (3,4-Methylenedioxy-alpha
180175 pyrrolidinobutyrophenone).
181176 101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
182177 102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).
183178 103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
184179 (Benocyclidine).
185180 104. F-MABP (Fluoromethylaminobutyrophenone).
186181 105. MeO-PBP (Methoxypyrrolidinobutyrophenone).
187182 106. Et-PBP (Ethylpyrrolidinobutyrophenone).
188183 107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
189184 108. Me-EABP (Methylethylaminobutyrophenone).
190185 109. Etizolam.
191186 110. PPP (Pyrrolidinopropiophenone).
192187 111. PBP (Pyrrolidinobutyrophenone).
193188 112. PVP (Pyrrolidinovalerophenone) or
194189 (Pyrrolidinopentiophenone).
195190 113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).
196191 114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
197192 115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
198193 116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
199194 117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
200195 118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
201196 119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
202197 120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
203198 121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
204199 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
205200 122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
206201 123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
207202 124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
208203 125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
209204 126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
210205 127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
211206 128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
212207 129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
213208 130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
214209 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
215210 ol).
216211 131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan
217212 2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]
218213 methanol).
219214 132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1
220215 methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene
221216 1,4-dione).
222217 133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
223218 134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)
219 undecanamide).
220 135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)
224221 undecanamide).
222 136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2
223 methyloctan-2-yl)phenol).
224 137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
225 135138. CB-52AM-2201 (N-Cyclopropyl-111-(2-hexyl-5-hydroxyphenoxy5-Fluoropentyl)-3-(1-naphthoyl)indole).
226 undecanamide).
226 139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
227 136140. CP 55,940RCS-8 (21-[3-Hydroxy-6-propanol-cyclohexyl](2-Cyclohexylethyl)-53-(2
228 methyloctan-2-ylmethoxyphenylacetyl)phenolindole).
229 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
230 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
231 naphthalenylmethanone).
232 142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4
233 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
234 naphthalenylmethanone).
235 143. Pentedrone (alpha-Methylaminovalerophenone).
229236 137144. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole)Fluoroamphetamine.
230237 138145. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole)Fluoromethamphetamine.
238 146. Methoxetamine.
239 147. Methiopropamine.
240 148. Methylbuphedrone (Methyl-alpha
241 methylaminobutyrophenone).
242 149. APB ((2-Aminopropyl)benzofuran).
243 150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
231244 139151. RCS-4UR-144 (1-Pentyl-3-(4-methoxybenzoyl)indole).2,2,3,3
245 tetramethylcyclopropanoyl)indole).
232246 140152. RCS-8XLR11 (1-(2-Cyclohexylethyl5-Fluoropentyl)-3-(2,2,3,3
247 tetramethylcyclopropanoyl)indole).
248 153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
249 tetramethylcyclopropanoyl)indole).
250 154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
251 155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
233252 methoxyphenylacetyliodobenzoyl)indole).
234 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
235 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
253 156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
254 carboxamide).
255 157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)
256 cyclohexylcarbamate).
257 158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
258 cyclohexyl ester).
259 159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1
236260 naphthalenylmethanonebenzoxazin-4-one).
261 160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
262 161. 2C-H (2,5-Dimethoxyphenethylamine).
263 162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
264 163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
237265 142164. WIN55,212-325I-NBOMe (4-Iodo-2,5-dimethoxy-[(3S)-2,3-Dihydro-5-methyl-3N-(42
238 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
239 naphthalenylmethanone).
266 methoxybenzyl)]phenethylamine).
240267 143165. PentedroneMDMA (alpha-Methylaminovalerophenone3,4-Methylenedioxymethamphetamine).
268 166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
269 167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
270 carboxylate).
271 168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
272 carboxylate).
241273 144169. Fluoroamphetamine.Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
274 3-carboxamide).
275 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
276 pentylindazole-3-carboxamide).
277 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
278 (4-fluorobenzyl)indazole-3-carboxamide).
279 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
280 1-pentylindazole-3-carboxamide).
242281 145173. Fluoromethamphetamine.Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
282 yl)-1-(fluoropentyl)indole-3-carboxamide).
283 174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
243 146284 methoxybenzyl)]phenethylamine). Methoxetamine.
244 147. Methiopropamine.
245 148. Methylbuphedrone (Methyl-alpha
285 175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
246286 methylaminobutyrophenonemethoxybenzyl)]phenethylamine).
247287 149176. APBAB-CHMINACA (N-(2-Aminopropyl1-Amino-3-methyl-1-oxobutan-2-yl)benzofuran).-1
288 (cyclohexylmethyl)indazole-3-carboxamide).
248289 150177. APDBFUB-PB-22 (8-Quinolinyl 1-(2-Aminopropyl4-fluorobenzyl)-2,3-dihydrobenzofuran).indole-3
290 carboxylate).
291 178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
292 3-carboxamide).
293 179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
294 (fluoropentyl)indazole-3-carboxamide).
295 180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
249296 151181. UR-144AM-855 (1-Pentyl-3(4aR,12bR)-(28-Hexyl-2,25,3,35-trimethyl
250 tetramethylcyclopropanoyl)indole).
251 152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
252 tetramethylcyclopropanoyl)indole).
253 153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
254 tetramethylcyclopropanoyl)indole).
255 154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
297 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
256298 155182. AM-2233AM-905 (1(6aR,9R,10aR)-3-[(N-Methyl-2-piperidinylE)methyl-Hept-1-enyl]-3-(29
257 iodobenzoyl)indole).
258 156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
259 carboxamide).
299 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
300 hexahydrobenzo[c]chromen-1-ol).
260301 157183. URB-597AM-906 ((6aR,9R,10aR)-3′-[(AminocarbonylZ)[1,1′-biphenylHept-1-enyl]-3-yl)9
261 cyclohexylcarbamate).
262 158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
263 cyclohexyl ester).
302 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
303 hexahydrobenzo[c]chromen-1-ol).
304 184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)
305 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
306 diol).
264307 159185. URB-754HU-243 (6-Methyl-2(6aR,8S,9S,10aR)-[9-(4-methylphenylHydroxymethyl)amino]-16,6
265 benzoxazin-4-one).
308 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a
309 tetrahydro-6aH-benzo[c]chromen-1-ol).
310 186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl
311 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
312 187. MAPB ((2-Methylaminopropyl)benzofuran).
266313 160188. 2C-D5-IT (4-Methyl-2,5-dimethoxyphenethylamine2-(1H-Indol-5-yl)-1-methyl-ethylamine).
267314 161189. 2C-H6-IT (2,5-Dimethoxyphenethylamine-(1H-Indol-6-yl)-1-methyl-ethylamine).
268 162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
269 163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
270 164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
271 methoxybenzyl)]phenethylamine).
272 165. MDMA (3,4-Methylenedioxymethamphetamine).
273 166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
274 167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
275 carboxylate).
276 168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
277 carboxylate).
278 169. Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
279 3-carboxamide).
280 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
281 pentylindazole-3-carboxamide).
282 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
283 (4-fluorobenzyl)indazole-3-carboxamide).
284 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
285 1-pentylindazole-3-carboxamide).
286 173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
287 yl)-1-(fluoropentyl)indole-3-carboxamide).
288 174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
289 methoxybenzyl)]phenethylamine).
290 175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
291 methoxybenzyl)]phenethylamine).
292 176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
293 (cyclohexylmethyl)indazole-3-carboxamide).
294 177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
295 carboxylate).
296 178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
297 3-carboxamide).
298 179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
299 (fluoropentyl)indazole-3-carboxamide).
300 180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
301 181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl
302 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
303 182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9
304 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
305 hexahydrobenzo[c]chromen-1-ol).
306 183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9
307 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
308 hexahydrobenzo[c]chromen-1-ol).
309 184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)
310 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
311 diol).
312 185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6
313 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a
314 tetrahydro-6aH-benzo[c]chromen-1-ol).
315 186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl
316 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
317 187. MAPB ((2-Methylaminopropyl)benzofuran).
318 188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
319 189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
320315 190. Synthetic Cannabinoids.—Unless specifically excepted
321316 or unless listed in another schedule or contained within a
322317 pharmaceutical product approved by the United States Food and
323318 Drug Administration, any material, compound, mixture, or
324319 preparation that contains any quantity of a synthetic
325320 cannabinoid found to be in any of the following chemical class
326321 descriptions, or homologues, nitrogen-heterocyclic analogs,
327322 isomers (including optical, positional, or geometric), esters,
328323 ethers, salts, and salts of homologues, nitrogen-heterocyclic
329324 analogs, isomers, esters, or ethers, whenever the existence of
330325 such homologues, nitrogen-heterocyclic analogs, isomers, esters,
331326 ethers, salts, and salts of isomers, esters, or ethers is
332327 possible within the specific chemical class or designation.
333328 Since nomenclature of these synthetically produced cannabinoids
334329 is not internationally standardized and may continually evolve,
335330 these structures or the compounds of these structures shall be
336331 included under this subparagraph, regardless of their specific
337332 numerical designation of atomic positions covered, if it can be
338333 determined through a recognized method of scientific testing or
339334 analysis that the substance contains properties that fit within
340335 one or more of the following categories:
341336 a. Tetrahydrocannabinols.—Any tetrahydrocannabinols
342337 naturally contained in a plant of the genus
Cannabis
, the
343338 synthetic equivalents of the substances contained in the plant
344339 or in the resinous extracts of the genus
Cannabis
, or synthetic
345340 substances, derivatives, and their isomers with similar chemical
346341 structure and pharmacological activity, including, but not
347342 limited to, Delta 9 tetrahydrocannabinols and their optical
348343 isomers, Delta 8 tetrahydrocannabinols and their optical
349344 isomers, Delta 6a,10a tetrahydrocannabinols and their optical
350345 isomers, or any compound containing a tetrahydrobenzo[c]chromene
351346 structure with substitution at either or both the 3-position or
352347 9-position, with or without substitution at the 1-position with
353348 hydroxyl or alkoxy groups, including, but not limited to:
354349 (I) Tetrahydrocannabinol.
355350 (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
356351 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
357352 ol).
358353 (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
359354 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
360355 ol).
361356 (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
362357 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
363358 (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
359 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
360 (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan
364361 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
365362 (VIVII) JWH-057JWH-359 ((6aR,10aR)-61-Methoxy-6,6,9-Trimethyl-39-trimethyl-3-(2-methyloctan2,3
363 dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
364 (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)
365 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
366 (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl
366367 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromenechromen-1-ol).
367 (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3
368 dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
369368 (VIIIX) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)Parahexyl.
370 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
371 (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl
372 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
373 (X) Parahexyl.
374369 b. Naphthoylindoles, Naphthoylindazoles,
375370 Naphthoylcarbazoles, Naphthylmethylindoles,
376371 Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any
377372 compound containing a naphthoylindole, naphthoylindazole,
378373 naphthoylcarbazole, naphthylmethylindole,
379374 naphthylmethylindazole, or naphthylmethylcarbazole structure,
380375 with or without substitution on the indole, indazole, or
381376 carbazole ring to any extent, whether or not substituted on the
382377 naphthyl ring to any extent, including, but not limited to:
383378 (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
384379 (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1
385380 naphthoyl)indole).
386381 (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
387382 (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
388383 (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
389384 (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
390385 (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
391386 (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
392387 (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
393388 (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
394389 (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
395390 (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
396391 (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
397392 (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1
398393 naphthoyl)indole).
399394 (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
400395 (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
401396 (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1
402397 naphthoyl)indole).
403398 (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).
404399 (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
405400 (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
406401 (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
407402 (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1
408403 naphthylmethyl]indole).
409404 (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1
410405 naphthoyl)indole).
411406 (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1
412407 naphthoyl)indole).
413408 (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
409 naphthoyl)indole).
410 (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
411 (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
412 (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
413 (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
414 (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
415 (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1
414416 naphthoyl)indole).
417 (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1
418 naphthoyl)indole).
419 (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1
420 naphthoyl)indole).
415421 (XXVIXXXIV) JWH-210Chloro JWH-018 (1-Pentyl-31-(4-ethyl-1-naphthoylChloropentyl)indole).-3-(1
422 naphthoyl)indole).
423 (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1
424 naphthoyl)indole).
416425 (XXVIIXXXVI) JWH-387AM-2232 (1-Pentyl-31-(4-bromo-1-naphthoyl4-Cyanobutyl)-3-(1-naphthoyl)indole).
426 (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1
427 naphthoyl)indazole).
417428 (XXVIIIXXXVIII) JWH-398MAM-2201 (1-Pentyl-31-(4-chloro-1-naphthoyl5-Fluoropentyl)indole).-3-(4-methyl-1
418 (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
419 (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
420 (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1
421 naphthoyl)indole).
422 (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1
423 naphthoyl)indole).
424 (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1
425 naphthoyl)indole).
426 (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1
427 naphthoyl)indole).
428 (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1
429 naphthoyl)indole).
430 (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1
431 naphthoyl)indole).
430432 (XXXVIXL) AM-2232EG-018 (1-(4-Cyanobutyl)-39-Pentyl-3-(1-naphthoyl)indolecarbazole).
431433 (XXXVIIXLI) THJ-2201EG-2201 (19-(5-Fluoropentyl)-3-(1
432434 naphthoyl)indazolecarbazole).
435 c. Naphthoylpyrroles.—Any compound containing a
436 naphthoylpyrrole structure, with or without substitution on the
437 pyrrole ring to any extent, whether or not substituted on the
438 naphthyl ring to any extent, including, but not limited to:
433439 (XXXVIIII) MAM-2201JWH-030 (11-Pentyl-3-(5-Fluoropentyl1-naphthoyl)-3-(4-methyl-1pyrrole).
440 (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
441 (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
442 (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
443 (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
444 (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1
434445 naphthoyl)indolepyrrole).
446 (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1
447 naphthoyl)pyrrole).
448 (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1
449 naphthoyl)pyrrole).
435450 (XXXIXIX) EAM-2201JWH-369 (11-Pentyl-5-(5-Fluoropentyl2-chlorophenyl)-3-(4-ethyl-11
451 naphthoyl)pyrrole).
452 (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1
436453 naphthoyl)indolepyrrole).
454 d. Naphthylmethylenindenes.—Any compound containing a
455 naphthylmethylenindene structure, with or without substitution
456 at the 3-position of the indene ring to any extent, whether or
457 not substituted on the naphthyl ring to any extent, including,
458 but not limited to, JWH-176 (3-Pentyl-1
459 (naphthylmethylene)indene).
437460 (XL)e. EG-018Phenylacetylindoles (9-Pentyl-3-(1-naphthoyl)carbazole)and Phenylacetylindazoles.—Any
461 compound containing a phenylacetylindole or phenylacetylindazole
462 structure, with or without substitution on the indole or
463 indazole ring to any extent, whether or not substituted on the
464 phenyl ring to any extent, including, but not limited to:
438465 (XLII) EG-2201JWH-167 (91-Pentyl-3-(5-Fluoropentylphenylacetyl)-3-(1indole).
466 (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
467 (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
468 (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
469 (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
470 (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
471 (VII) Cannabipiperidiethanone.
472 (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2
439473 naphthoylmethoxyphenylacetyl)carbazoleindole).
440474 cf. NaphthoylpyrrolesCyclohexylphenols.—Any compound containing a
441475 naphthoylpyrrolecyclohexylphenol structure, with or without substitution onat the
442476 pyrrole5-position of the phenolic ring to any extent, whether or not substituted on the
443477 naphthylsubstituted on the cyclohexyl ring to any extent, including, but not limited to:
444 (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
478 not limited to:
445479 (III) JWH-031CP 47,497 (1-Hexyl-32-(1-naphthoyl3-Hydroxycyclohexyl)pyrrole).-5-(2-methyloctan-2
446 (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
447 (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
448 (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
449 (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1
450480 naphthoylyl)pyrrolephenol).
451 (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1
481 (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
452482 naphthoyl)pyrrolehomologue).
483 (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2
484 methyloctan-2-yl)phenol).
485 g. Benzoylindoles and Benzoylindazoles.—Any compound
486 containing a benzoylindole or benzoylindazole structure, with or
487 without substitution on the indole or indazole ring to any
488 extent, whether or not substituted on the phenyl ring to any
489 extent, including, but not limited to:
453490 (VIIII) JWH-368AM-679 (1-Pentyl-51-Pentyl-3-(3-fluorophenyl2-iodobenzoyl)-3-(1indole).
491 (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
492 (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
493 iodo-5-nitrobenzoyl)indole).
494 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4
454495 naphthoylmethoxybenzoyl)pyrroleindole).
496 (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
497 iodobenzoyl)indole).
455498 (IXVI) JWH-369RCS-4 (1-Pentyl-51-Pentyl-3-(2-chlorophenyl4-methoxybenzoyl)-3-(1indole).
456 naphthoyl)pyrrole).
457499 (XVII) JWH-370RCS-4 C4 homologue (1-Pentyl-51-Butyl-3-(2-methylphenyl)-3-(14
458 naphthoyl)pyrrole).
459 d. Naphthylmethylenindenes.—Any compound containing a
460 naphthylmethylenindene structure, with or without substitution
461 at the 3-position of the indene ring to any extent, whether or
462 not substituted on the naphthyl ring to any extent, including,
463 but not limited to, JWH-176 (3-Pentyl-1
464 (naphthylmethylene)indene).
465 e. Phenylacetylindoles and Phenylacetylindazoles.—Any
466 compound containing a phenylacetylindole or phenylacetylindazole
467 structure, with or without substitution on the indole or
468 indazole ring to any extent, whether or not substituted on the
469 phenyl ring to any extent, including, but not limited to:
470 (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
471 (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
472 (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
473 (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
474 (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
475 (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
476 (VII) Cannabipiperidiethanone.
477 (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2
478 methoxyphenylacetyl)indole).
479 f. Cyclohexylphenols.—Any compound containing a
480 cyclohexylphenol structure, with or without substitution at the
481 5-position of the phenolic ring to any extent, whether or not
482 substituted on the cyclohexyl ring to any extent, including, but
483 not limited to:
484 (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
485 yl)phenol).
486 (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
487 homologue).
488 (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2
489 methyloctan-2-yl)phenol).
490 g. Benzoylindoles and Benzoylindazoles.—Any compound
491 containing a benzoylindole or benzoylindazole structure, with or
492 without substitution on the indole or indazole ring to any
493 extent, whether or not substituted on the phenyl ring to any
494 extent, including, but not limited to:
495 (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
496 (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
497 (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
498 iodo-5-nitrobenzoyl)indole).
499 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4
500 methoxybenzoyl)indole).
501 (VVIII) AM-2233AM-630 (1-[2-(N-Methyl-2-piperidinyl4-Morpholinyl)methylethyl]-3-(22-methyl-6-iodo
502 iodobenzoyl3-(4-methoxybenzoyl)indole).
503 h. Tetramethylcyclopropanoylindoles and
504 Tetramethylcyclopropanoylindazoles.—Any compound containing a
505 tetramethylcyclopropanoylindole or
506 tetramethylcyclopropanoylindazole structure, with or without
507 substitution on the indole or indazole ring to any extent,
508 whether or not substituted on the tetramethylcyclopropyl group
509 to any extent, including, but not limited to:
503510 (VII) RCS-4UR-144 (1-Pentyl-3-(4-methoxybenzoyl)indole).2,2,3,3
511 tetramethylcyclopropanoyl)indole).
512 (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
513 tetramethylcyclopropanoyl)indole).
504514 (VIIIII) RCS-4Chloro C4 homologueUR-144 (1-Butyl-31-(4Chloropentyl)-3-(2,2,3,3
505515 methoxybenzoyltetramethylcyclopropanoyl)indole).
506516 (VIIIIV) AM-630A-796,260 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo3-(2,2,3,3
507517 3-(4-methoxybenzoyltetramethylcyclopropanoyl)indole).
518 (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3
508 h519 tetramethylcyclopropanoyl)indole). Tetramethylcyclopropanoylindoles and
520 (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3
521 tetramethylcyclopropanoyl)indole).
522 (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3
523 tetramethylcyclopropanoyl)indole).
524 (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3
509525 Tetramethylcyclopropanoylindazolestetramethylcyclopropanoyl)indazole).—Any compound containing a
526 (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3
510527 tetramethylcyclopropanoylindole ortetramethylcyclopropanoyl)indole).
528 (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3
511529 tetramethylcyclopropanoylindazole structure, with or withouttetramethylcyclopropanoyl)indole).
530 i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole
531 carboxamides, and Adamantylindazole carboxamides.—Any compound
532 containing an adamantoyl indole, adamantoyl indazole, adamantyl
533 indole carboxamide, or adamantyl indazole carboxamide structure,
512534 with or without substitution on the indole or indazole ring to any extent,
513535 any extent, whether or not substituted on the tetramethylcyclopropyladamantyl groupring to
514536 to any extent, including, but not limited to:
537 (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
538 (II) Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
539 3-carboxamide).
540 (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
541 carboxamide).
515542 (IIV) UR-144AM-1248 (1-Pentyl-31-(2,2,3,31-Methylpiperidine)methyl-3-(1
516543 tetramethylcyclopropanoyladamantoyl)indole).
544 (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).
545 (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
517546 (IIVII) XLR11Fluoro AB-001 (1-(5-FluoropentylFluoropentyl)-3-(2,2,3,31
518547 tetramethylcyclopropanoyladamantoyl)indole).
519 (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
520 tetramethylcyclopropanoyl)indole).
521 (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3
522 tetramethylcyclopropanoyl)indole).
523 (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3
524 tetramethylcyclopropanoyl)indole).
525 (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3
526 tetramethylcyclopropanoyl)indole).
527 (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3
528 tetramethylcyclopropanoyl)indole).
529 (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3
530 tetramethylcyclopropanoyl)indazole).
531 (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3
532 tetramethylcyclopropanoyl)indole).
533 (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3
534 tetramethylcyclopropanoyl)indole).
535548 ij. AdamantoylindolesQuinolinylindolecarboxylates, Adamantoylindazoles, Adamantylindole
549 Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
550 and Quinolinylindazolecarboxamides.—Any compound containing a
551 quinolinylindole carboxylate, quinolinylindazole carboxylate,
552 isoquinolinylindole carboxylate, isoquinolinylindazole
553 carboxylate, quinolinylindole carboxamide, quinolinylindazole
536554 carboxamidescarboxamide, andisoquinolinylindole Adamantylindazolecarboxamide, carboxamides.—Any compoundor
555 isoquinolinylindazole carboxamide structure, with or without
537556 containingsubstitution anon adamantoylthe indole, adamantoylor indazole ring to any extent, adamantyl
538 indole carboxamide, or adamantyl indazole carboxamide structure,
539557 withwhether or withoutnot substitutionsubstituted on the indolequinoline or indazoleisoquinoline ring to
540558 to any extent, whetherincluding, orbut not substituted on the adamantyl ringlimited to:
541 any extent, including, but not limited to:
542559 (I) AKB48PB-22 (N-Adamant-1-yl8-Quinolinyl 1-pentylindazole-3-carboxamide1-pentylindole-3-carboxylate).
560 (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
561 carboxylate).
562 (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
563 carboxylate).
564 (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
565 carboxylate).
566 (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
543567 (IIVI) Fluoro AKB48NPB-22 (N-Adamant-1-yl8-Quinolinyl 1-(fluoropentyl)indazole
568 3-carboxylate).
569 (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole
570 3-carboxylate).
571 (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
572 (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3
544573 3-carboxamidecarboxamide).
574 k. Naphthylindolecarboxylates and
575 Naphthylindazolecarboxylates.—Any compound containing a
576 naphthylindole carboxylate or naphthylindazole carboxylate
577 structure, with or without substitution on the indole or
578 indazole ring to any extent, whether or not substituted on the
579 naphthyl ring to any extent, including, but not limited to:
545580 (IIII) STS-135NM-2201 (N-Adamant-1-yl1-Naphthalenyl 1-(5-fluoropentyl)indole-3
546581 carboxamidecarboxylate).
547582 (IVII) AM-1248SDB-005 (1-(1-Methylpiperidine)methyl-3-(11-Naphthalenyl 1-pentylindazole-3
548583 adamantoyl)indolecarboxylate).
584 (III) Fluoro SDB-005 (1-Naphthalenyl 1
585 (fluoropentyl)indazole-3-carboxylate).
549586 (VIV) AB-001FDU-PB-22 (1-Pentyl-31-Naphthalenyl 1-(1-adamantoyl4-fluorobenzyl)indole).indole-3
587 carboxylate).
550588 (VIV) APICA3-CAF (N-Adamant-1-yl2-Naphthalenyl 1-pentylindole-3-carboxamide1-(2-fluorophenyl).indazole-3
589 carboxylate).
590 l. Naphthylindole carboxamides and Naphthylindazole
591 carboxamides.—Any compound containing a naphthylindole
592 carboxamide or naphthylindazole carboxamide structure, with or
593 without substitution on the indole or indazole ring to any
594 extent, whether or not substituted on the naphthyl ring to any
595 extent, including, but not limited to:
551596 (VIII) Fluoro AB-001NNEI (1-(FluoropentylN-Naphthalen-1-yl 1-pentylindole-3-carboxamide)-3-(1.
597 (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
598 3-carboxamide).
599 (III) Chloro-NNEI (N-Naphthalen-1-yl 1
600 (chloropentyl)indole-3-carboxamide).
601 (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3
552602 adamantoyl)indolecarboxamide).
603 (V) Fluoro MN-18 (N-Naphthalen-1-yl 1
604 (fluoropentyl)indazole-3-carboxamide).
553605 jm. QuinolinylindolecarboxylatesAlkylcarbonyl indole carboxamides, Alkylcarbonyl
606 indazole carboxamides, Alkylcarbonyl indole carboxylates, and
607 Alkylcarbonyl indazole carboxylates.—Any compound containing an
608 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
609 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3
610 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
611 indole carboxamide, indazole carboxamide, indole carboxylate, or
554612 Quinolinylindazolecarboxylatesindazole carboxylate, Quinolinylindolecarboxamides,with or without substitution on the indole
613 or indazole ring to any extent, whether or not substituted on
614 the alkylcarbonyl group to any extent, including, but not
615 limited to:
616 (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1
555617 and Quinolinylindazolecarboxamidespentylindole-3-carboxamide).—Any compound containing a
618 (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
619 yl)-1-(fluoropentyl)indole-3-carboxamide).
620 (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
621 (fluoropentyl)indole-3-carboxamide).
622 (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
556623 quinolinylindole carboxylate, quinolinylindazole carboxylate,pentylindazole-3-carboxamide).
557 isoquinolinylindole carboxylate, isoquinolinylindazole
558 carboxylate, quinolinylindole carboxamide, quinolinylindazole
559 carboxamide, isoquinolinylindole carboxamide, or
624 (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)
625 1-(fluoropentyl)indazole-3-carboxamide).
626 (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
560627 isoquinolinylindazole carboxamide structure, with or without1-pentylindazole-3-carboxamide).
561 substitution on the indole or indazole ring to any extent,
562 whether or not substituted on the quinoline or isoquinoline ring
563 to any extent, including, but not limited to:
628 (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1
564 629 oxobutan-2-yl)-1-(Ifluoropentyl) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylateindazole-3-carboxamide).
565630 (IIVIII) Fluoro PB-22AB-FUBINACA (8-Quinolinyl 1N-(fluoropentyl1-Amino-3-methyl-1-oxobutan-2-yl)indole-3-1
566 carboxylate).
631 (4-fluorobenzyl)indazole-3-carboxamide).
632 (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
633 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
634 (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
635 (cyclohexylmethyl)indazole-3-carboxamide).
636 (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
567 (III) BB-22 (8-Quinolinyl 1-637 (cyclohexylmethyl)indole-3indazole-3-carboxamide).
638 (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
639 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
640 (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
568641 carboxylatepentylindazole-3-carboxamide).
642 (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
643 (fluoropentyl)indazole-3-carboxamide).
644 (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4
645 fluorobenzyl)indazole-3-carboxamide).
646 (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
647 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
648 (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
569 (IV649 2-yl) FUB-PB-22 (8-Quinolinyl -1-(4-fluorobenzyl)indole-3indazole-3-carboxamide).
570 carboxylate).
650 (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
651 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
652 (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
653 fluoropentyl)indole-3-carboxamide).
654 (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
571 (V655 fluoropentyl) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylateindazole-3-carboxamide).
572656 (VIXXI) Fluoro NPB-22PX-3 (8-Quinolinyl 1N-(fluoropentyl1-Amino-1-oxo-3-phenylpropan-2-yl)indazole-1
657 (cyclohexylmethyl)indazole-3-carboxamide).
658 (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4
573659 3-carboxylatefluorobenzyl)indazole-3-carboxamide).
574 (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole
660 (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
575661 3-carboxylate2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
662 n. Cumylindolecarboxamides and Cumylindazolecarboxamides.
663 Any compound containing a N-(2-phenylpropan-2-yl) indole
664 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
665 structure, with or without substitution on the indole or
666 indazole ring to any extent, whether or not substituted on the
667 phenyl ring of the cumyl group to any extent, including, but not
668 limited to:
576669 (VIIII) THJCUMYL-PICA (8-Quinolinyl 1-pentylindazole-3-carboxamideN-(2-Phenylpropan-2-yl).-1-pentylindole-3
670 carboxamide).
577671 (IXII) Fluoro THJCUMYL-PICA (8-Quinolinyl 1N-(fluoropentyl2-Phenylpropan-2-yl)indazole-3-1
578672 carboxamide(fluoropentyl)indole-3-carboxamide).
579 k. Naphthylindolecarboxylates and
580 Naphthylindazolecarboxylates.—Any compound containing a
581 naphthylindole carboxylate or naphthylindazole carboxylate
673 o. Other Synthetic Cannabinoids.—Any material, compound,
674 mixture, or preparation that contains any quantity of a
675 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
676 (I) With or without modification or replacement of a
677 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
678 between either two core rings, or linkage between a core ring
582679 and group structure, with or without substitution on the indoleaddition of a carbon or
680 replacement of a carbon;
681 (II) With or without replacement of a core ring or group
583682 indazole ring to any extentstructure, whether or not substituted on the ring or group
584 naphthyl ring to any extent, including, but not limited to:
585 (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3
586 carboxylate).
587 (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3
588 carboxylate).
589 (III) Fluoro SDB-005 (1-Naphthalenyl 1
590 (fluoropentyl)indazole-3-carboxylate).
591 (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3
592 carboxylate).
593 (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3
594 carboxylate).
595 l. Naphthylindole carboxamides and Naphthylindazole
596 carboxamides.—Any compound containing a naphthylindole
597 carboxamide or naphthylindazole carboxamide structure, with or
598 without substitution on the indole or indazole ring to any
599 extent, whether or not substituted on the naphthyl ring to any
600 extent, including, but not limited to:
601 (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
602 (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
603 3-carboxamide).
604 (III) Chloro-NNEI (N-Naphthalen-1-yl 1
605 (chloropentyl)indole-3-carboxamide).
606 (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3
607 carboxamide).
608 (V) Fluoro MN-18 (N-Naphthalen-1-yl 1
609 (fluoropentyl)indazole-3-carboxamide).
610 m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl
611 indazole carboxamides, Alkylcarbonyl indole carboxylates, and
612 Alkylcarbonyl indazole carboxylates.—Any compound containing an
613 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
614 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3
615 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
616 indole carboxamide, indazole carboxamide, indole carboxylate, or
617 indazole carboxylate, with or without substitution on the indole
618683 or indazole ringstructures to any extent,; whether or not substituted onand
619 the alkylcarbonyl group to any extent, including, but not
620 limited to:
621 (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1
622 pentylindole-3-carboxamide).
623 (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
624 yl)-1-(fluoropentyl)indole-3-carboxamide).
625 (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
626 (fluoropentyl)indole-3-carboxamide).
627 (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
628 pentylindazole-3-carboxamide).
629 (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)
630 1-(fluoropentyl)indazole-3-carboxamide).
631 (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
632 1-pentylindazole-3-carboxamide).
633 (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1
634 oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
635 (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
636 (4-fluorobenzyl)indazole-3-carboxamide).
637 (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
638 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
639 (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
640 (cyclohexylmethyl)indazole-3-carboxamide).
641 (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
642 (cyclohexylmethyl)indazole-3-carboxamide).
643 (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
644 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
645 (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
646 pentylindazole-3-carboxamide).
647 (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
648 (fluoropentyl)indazole-3-carboxamide).
649 (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4
650 fluorobenzyl)indazole-3-carboxamide).
651 (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
652 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
653 (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
654 2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
655 (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
656 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
657 (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
658 fluoropentyl)indole-3-carboxamide).
659 (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
660 fluoropentyl)indazole-3-carboxamide).
661 (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1
662 (cyclohexylmethyl)indazole-3-carboxamide).
663 (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4
664 fluorobenzyl)indazole-3-carboxamide).
665 (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
666 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
667 n. Cumylindolecarboxamides and Cumylindazolecarboxamides.
668 Any compound containing a N-(2-phenylpropan-2-yl) indole
669 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
670 structure, with or without substitution on the indole or
671 indazole ring to any extent, whether or not substituted on the
672 phenyl ring of the cumyl group to any extent, including, but not
673 limited to:
674 (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3
675 carboxamide).
676 (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1
677 (fluoropentyl)indole-3-carboxamide).
678684 o.(III) OtherIs Synthetica Cannabinoids.—Anycannabinoid materialreceptor agonist, compound,unless
679 mixture, or preparation that contains any quantity of a
680 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
681 (I) With or without modification or replacement of a
682 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
685 specifically excepted or unless listed in another schedule or
686 contained within a pharmaceutical product approved by the United
687 States Food and Drug Administration.
688 191. Substituted Cathinones.—Unless specifically excepted,
683689 betweenlisted eitherin twoanother core ringsschedule, or linkagecontained betweenwithin a core ringpharmaceutical
684 and group structure, with or without the addition of a carbon or
685 replacement of a carbon;
686 (II) With or without replacement of a core ring or group
687 structure, whether or not substituted on the ring or group
690 product approved by the United States Food and Drug
691 Administration, any material, compound, mixture, or preparation,
692 including its salts, isomers, esters, or ethers, and salts of
693 isomers, esters, or ethers, whenever the existence of such salts
694 is possible within any of the following specific chemical
695 designations:
696 a. Any compound containing a 2-amino-1-phenyl-1-propanone
688697 structures to any extentstructure; and
689 (III) Is a cannabinoid receptor agonist, unless
690 specifically excepted or unless listed in another schedule or
691 contained within a pharmaceutical product approved by the United
692 States Food and Drug Administration.
693 191. Substituted Cathinones.—Unless specifically excepted,
694 listed in another schedule, or contained within a pharmaceutical
695 product approved by the United States Food and Drug
696 Administration, any material, compound, mixture, or preparation,
697 including its salts, isomers, esters, or ethers, and salts of
698 isomers, esters, or ethers, whenever the existence of such salts
699 is possible within any of the following specific chemical
700 designations:
701698 ab. Any compound containing a 2-amino-1-phenyl-1-propanone2-amino-1-naphthyl-1-propanone
702699 structure; or
703700 bc. Any compound containing a 2-amino-1-naphthyl-1-propanone2-amino-1-thiophenyl-1
704701 propanone structure; or,
705 c. Any compound containing a 2-amino-1-thiophenyl-1
706 propanone structure,
707702
708703 whether or not the compound is further modified:
709704 (I) With or without substitution on the ring system to any
710705 extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
711706 haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
712707 dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
713708 substituents;
714709 (II) With or without substitution at the 3-propanone
715710 position with an alkyl substituent or removal of the methyl
716711 group at the 3-propanone position;
717712 (III) With or without substitution at the 2-amino nitrogen
718713 atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
719714 not further substituted in the ring system; or
720715 (IV) With or without inclusion of the 2-amino nitrogen atom
721716 in a cyclic structure, including, but not limited to:
722717 (A) Methcathinone.
723718 (B) Ethcathinone.
724719 (C) Methylone (3,4-Methylenedioxymethcathinone).
725720 (D) 2,3-Methylenedioxymethcathinone.
726721 (E) MDPV (3,4-Methylenedioxypyrovalerone).
727722 (F) Methylmethcathinone.
728723 (G) Methoxymethcathinone.
729724 (H) Fluoromethcathinone.
730725 (I) Methylethcathinone.
731726 (J) Butylone (3,4-Methylenedioxy-alpha
732727 methylaminobutyrophenone).
733728 (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
734729 (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).
735730 (M) Naphyrone (Naphthylpyrovalerone).
736731 (N) Bromomethcathinone.
737732 (O) Buphedrone (alpha-Methylaminobutyrophenone).
738733 (P) Eutylone (3,4-Methylenedioxy-alpha
739734 ethylaminobutyrophenone).
740735 (Q) Dimethylcathinone.
741736 (R) Dimethylmethcathinone.
742737 (S) Pentylone (3,4-Methylenedioxy-alpha
743738 methylaminovalerophenone).
744739 (T) Pentedrone (alpha-Methylaminovalerophenone).
745740 (U) MDPPP (3,4-Methylenedioxy-alpha
746741 pyrrolidinopropiophenone).
747742 (V) MDPBP (3,4-Methylenedioxy-alpha
748743 pyrrolidinobutyrophenone).
749744 (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).
750745 (X) PPP (Pyrrolidinopropiophenone).
751746 (Y) PVP (Pyrrolidinovalerophenone) or
752747 (Pyrrolidinopentiophenone).
753748 (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
754749 (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).
755750 (BB) F-MABP (Fluoromethylaminobutyrophenone).
756751 (CC) Me-EABP (Methylethylaminobutyrophenone).
757752 (DD) PBP (Pyrrolidinobutyrophenone).
758753 (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).
759754 (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).
760755 (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
761756 (HH) Dimethylone (3,4-Methylenedioxy-N,N
762757 dimethylcathinone).
763758 (II) 3,4-Methylenedioxy-N,N-diethylcathinone.
764759 (JJ) 3,4-Methylenedioxy-N-acetylcathinone.
765760 (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.
766761 (LL) 3,4-Methylenedioxy-N-acetylethcathinone.
767762 (MM) Methylbuphedrone (Methyl-alpha
768763 methylaminobutyrophenone).
769764 (NN) Methyl-alpha-methylaminohexanophenone.
770765 (OO) N-Ethyl-N-methylcathinone.
771766 (PP) PHP (Pyrrolidinohexanophenone).
772767 (QQ) PV8 (Pyrrolidinoheptanophenone).
773768 (RR) Chloromethcathinone.
774769 (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
775770 192. Substituted Phenethylamines.—Unless specifically
776771 excepted or unless listed in another schedule, or contained
777772 within a pharmaceutical product approved by the United States
778773 Food and Drug Administration, any material, compound, mixture,
779774 or preparation, including its salts, isomers, esters, or ethers,
780775 and salts of isomers, esters, or ethers, whenever the existence
781776 of such salts is possible within any of the following specific
782777 chemical designations, any compound containing a phenethylamine
783778 structure, without a beta-keto group, and without a benzyl group
784779 attached to the amine group, whether or not the compound is
785780 further modified with or without substitution on the phenyl ring
786781 to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
787782 halide, fused alkylenedioxy, fused furan, fused benzofuran,
788783 fused dihydrofuran, or fused tetrahydropyran substituents,
789784 whether or not further substituted on a ring to any extent, with
790785 or without substitution at the alpha or beta position by any
791786 alkyl substituent, with or without substitution at the nitrogen
792787 atom, and with or without inclusion of the 2-amino nitrogen atom
793788 in a cyclic structure, including, but not limited to:
794789 a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
795790 b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
796791 c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
797792 d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
798793 e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
799794 f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
800795 g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
801796 h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
802797 i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
803798 j. 2C-H (2,5-Dimethoxyphenethylamine).
804799 k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
805800 l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
806801 m. MDMA (3,4-Methylenedioxymethamphetamine).
807802 n. MBDB (Methylbenzodioxolylbutanamine) or (3,4
808803 Methylenedioxy-N-methylbutanamine).
809804 o. MDA (3,4-Methylenedioxyamphetamine).
810805 p. 2,5-Dimethoxyamphetamine.
811806 q. Fluoroamphetamine.
812807 r. Fluoromethamphetamine.
813808 s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
814809 t. DOB (4-Bromo-2,5-dimethoxyamphetamine).
815810 u. DOC (4-Chloro-2,5-dimethoxyamphetamine).
816811 v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).
817812 w. DOI (4-Iodo-2,5-dimethoxyamphetamine).
818813 x. DOM (4-Methyl-2,5-dimethoxyamphetamine).
819814 y. PMA (4-Methoxyamphetamine).
820815 z. N-Ethylamphetamine.
821816 aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.
822817 bb. 5-Methoxy-3,4-methylenedioxyamphetamine.
823818 cc. PMMA (4-Methoxymethamphetamine).
824819 dd. N,N-Dimethylamphetamine.
825820 ee. 3,4,5-Trimethoxyamphetamine.
826821 ff. 4-APB (4-(2-Aminopropyl)benzofuran).
827822 gg. 5-APB (5-(2-Aminopropyl)benzofuran).
828823 hh. 6-APB (6-(2-Aminopropyl)benzofuran).
829824 ii. 7-APB (7-(2-Aminopropyl)benzofuran).
830825 jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
831826 kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
832827 ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
833828 mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
834829 nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).
835830 oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).
836831 pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).
837832 qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).
838833 rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
839834 ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3
840835 dihydrobenzofuran),
841
836
842837 which does not include phenethylamine, mescaline as described in
843838 subparagraph 20., substituted cathinones as described in
844839 subparagraph 191., N-Benzyl phenethylamine compounds as
845840 described in subparagraph 193., or methamphetamine as described
846841 in subparagraph (2)(c)5.
847842 193. N-Benzyl Phenethylamine Compounds.—Unless specifically
848843 excepted or unless listed in another schedule, or contained
849844 within a pharmaceutical product approved by the United States
850845 Food and Drug Administration, any material, compound, mixture,
851846 or preparation, including its salts, isomers, esters, or ethers,
852847 and salts of isomers, esters, or ethers, whenever the existence
853848 of such salts is possible within any of the following specific
854849 chemical designations, any compound containing a phenethylamine
855850 structure without a beta-keto group, with substitution on the
856851 nitrogen atom of the amino group with a benzyl substituent, with
857852 or without substitution on the phenyl or benzyl ring to any
858853 extent with alkyl, alkoxy, thio, alkylthio, halide, fused
859854 alkylenedioxy, fused furan, fused benzofuran, or fused
860855 tetrahydropyran substituents, whether or not further substituted
861856 on a ring to any extent, with or without substitution at the
862857 alpha position by any alkyl substituent, including, but not
863858 limited to:
864859 a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
865860 methoxybenzyl)]phenethylamine).
866861 b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2
867862 hydroxybenzyl)]phenethylamine).
868863 c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2
869864 fluorobenzyl)]phenethylamine).
870865 d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3
871866 methylenedioxybenzyl)]phenethylamine).
872867 e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
873868 methoxybenzyl)]phenethylamine).
874869 f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2
875870 hydroxybenzyl)]phenethylamine).
876871 g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2
877872 fluorobenzyl)]phenethylamine).
878873 h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3
879874 methylenedioxybenzyl)]phenethylamine).
880875 i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2
876 methoxybenzyl)]phenethylamine).
877 j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2
881878 methoxybenzyl)]phenethylamine).
882879 jk. 25T4-NBOMe25T7-NBOMe (4-Isopropylthio-24-(n)-Propylthio-2,5-dimethoxy-[N-(2
883880 methoxybenzyl)]phenethylamine).
884881 kl. 25T7-NBOMe25C-NBOMe (4-(n)-Propylthio-24-Chloro-2,5-dimethoxy-[N-(2
885882 methoxybenzyl)]phenethylamine).
886883 lm. 25C-NBOMe25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2
884 hydroxybenzyl)]phenethylamine).
885 n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2
886 fluorobenzyl)]phenethylamine).
887 o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3
888 methylenedioxybenzyl)]phenethylamine).
889 p. 25H-NBOMe (2,5-Dimethoxy-[N-(2
887890 methoxybenzyl)]phenethylamine).
891 q. 25H-NBOH (2,5-Dimethoxy-[N-(2
892 hydroxybenzyl)]phenethylamine).
893 r. 25H-NBF (2,5-Dimethoxy-[N-(2
894 fluorobenzyl)]phenethylamine).
888895 ms. 25C-NBOH25D-NBOMe (4-Chloro-24-Methyl-2,5-dimethoxy-[N-(2
889896 hydroxybenzylmethoxybenzyl)]phenethylamine).,
890 n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2
891 fluorobenzyl)]phenethylamine).
892 o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3
893 methylenedioxybenzyl)]phenethylamine).
894 p. 25H-NBOMe (2,5-Dimethoxy-[N-(2
895 methoxybenzyl)]phenethylamine).
896 q. 25H-NBOH (2,5-Dimethoxy-[N-(2
897 hydroxybenzyl)]phenethylamine).
898 r. 25H-NBF (2,5-Dimethoxy-[N-(2
899 fluorobenzyl)]phenethylamine).
900 s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2
901 methoxybenzyl)]phenethylamine),
902
897
903898 which does not include substituted cathinones as described in
904899 subparagraph 191.
905900 194. Substituted Tryptamines.—Unless specifically excepted
906901 or unless listed in another schedule, or contained within a
907902 pharmaceutical product approved by the United States Food and
908903 Drug Administration, any material, compound, mixture, or
909904 preparation containing a 2-(1H-indol-3-yl)ethanamine, for
910905 example tryptamine, structure with or without mono- or di
911906 substitution of the amine nitrogen with alkyl or alkenyl groups,
912907 or by inclusion of the amino nitrogen atom in a cyclic
913908 structure, whether or not substituted at the alpha position with
914909 an alkyl group, whether or not substituted on the indole ring to
915910 any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
916911 groups, including, but not limited to:
917912 a. Alpha-Ethyltryptamine.
918913 b. Bufotenine.
919914 c. DET (Diethyltryptamine).
920915 d. DMT (Dimethyltryptamine).
921916 e. MET (N-Methyl-N-ethyltryptamine).
922917 f. DALT (N,N-Diallyltryptamine).
923918 g. EiPT (N-Ethyl-N-isopropyltryptamine).
924919 h. MiPT (N-Methyl-N-isopropyltryptamine).
925920 i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
926921 j. 5-Hydroxy-N-methyltryptamine.
927922 k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
928923 l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
929924 m. Methyltryptamine.
930925 n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
931926 o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
932927 p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
933928 q. DiPT (N,N-Diisopropyltryptamine).
934929 r. DPT (N,N-Dipropyltryptamine).
935930 s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
936931 t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
937932 u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
938933 v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
939934 w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
940935 x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
941936 y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N
942937 isopropyltryptamine).
943938 z. Methyl-alpha-ethyltryptamine.
944939 aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),
945940
946941 which does not include tryptamine, psilocyn as described in
947942 subparagraph 34., or psilocybin as described in subparagraph 33.
948943 195. Substituted Phenylcyclohexylamines.—Unless
949944 specifically excepted or unless listed in another schedule, or
950945 contained within a pharmaceutical product approved by the United
951946 States Food and Drug Administration, any material, compound,
952947 mixture, or preparation containing a phenylcyclohexylamine
953948 structure, with or without any substitution on the phenyl ring,
954949 any substitution on the cyclohexyl ring, any replacement of the
955950 phenyl ring with a thiophenyl or benzothiophenyl ring, with or
956951 without substitution on the amine with alkyl, dialkyl, or alkoxy
957952 substituents, inclusion of the nitrogen in a cyclic structure,
958953 or any combination of the above, including, but not limited to:
959954 a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
960955 (Benocyclidine).
961956 b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
962957 of phencyclidine).
963958 c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
959 analog of phencyclidine).
960 d. PCPr (Phenylcyclohexylpropylamine).
961 e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
964962 analog of phencyclidine).
963 f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).
965964 dg. PCPrPCMPA (PhenylcyclohexylpropylaminePhenylcyclohexyl(methoxypropylamine)).
965 h. Methoxetamine.
966 i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
966967 ej. TCPBromo-PCP (1-[1-(2-ThienylBromophenyl)-cyclohexyl]-piperidinecyclohexylpiperidine)(Thiophene.
968 k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
969 l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
970 m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
971 n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
972 o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
973 p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
967 analog974 q. Oxo-PCP of phencyclidine((Oxophenyl)cyclohexylpiperidine).
968975 fr. PCEEAAmino-PCP (Phenylcyclohexyl(ethoxyethylamineAminophenyl)cyclohexylpiperidine).
976 196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2
977 piperidinylidene]-benzenesulfonamide.
978 197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2
979 piperidinylidene]-benzenesulfonamide.
980 198. AH-7921, 3,4-dichloro-N-[[1
969 g981 (dimethylamino)cyclohexyl]methyl]-benzamide. PCMPA (Phenylcyclohexyl(methoxypropylamine)).
982 199. U47700, trans-3,4-dichloro-N-[2
983 (dimethylamino)cyclohexyl]-N-methyl-benzamide.
984 200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
985 dihydrochloride.
986 Section 2. Paragraph (i) of subsection (1) of section
987 893.13, Florida Statutes, is amended to read:
988 893.13 Prohibited acts; penalties.—
970989 h. Methoxetamine.(1)
971 i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
972 j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).
973 k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
974 l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
975 m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
976 n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
977 o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
978 p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
979 q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).
980 r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).
981 196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2
982 piperidinylidene]-benzenesulfonamide.
983 197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2
984 piperidinylidene]-benzenesulfonamide.
985 198. AH-7921, 3,4-dichloro-N-[[1
986 (dimethylamino)cyclohexyl]methyl]-benzamide.
987 199. U47700, trans-3,4-dichloro-N-[2
988 (dimethylamino)cyclohexyl]-N-methyl-benzamide.
989 200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
990 (i) Except as authorized by this chapter, a person commits
991 a felony of the first degree, punishable as provided in s.
992 775.082, s. 775.083, or s. 775.084, and must be sentenced to a
993 mandatory minimum term of imprisonment of 3 years, if:
994 1. The person sells, manufactures, or delivers, or
995 possesses with intent to sell, manufacture, or deliver, any of
990996 dihydrochloride.the following:
991 (3) SCHEDULE III.—A substance in Schedule III has a
992 potential for abuse less than the substances contained in
993 Schedules I and II and has a currently accepted medical use in
994 treatment in the United States, and abuse of the substance may
995 lead to moderate or low physical dependence or high
996 psychological dependence or, in the case of anabolic steroids,
997 may lead to physical damage. The following substances are
998 controlled in Schedule III:
999 (a) Unless specifically excepted or unless listed in
1000 another schedule, any material, compound, mixture, or
1001 preparation which contains any quantity of the following
1002 substances having a depressant or stimulant effect on the
1003 nervous system:
1004 1. Any substance which contains any quantity of a
1005 derivative of barbituric acid, including thiobarbituric acid, or
1006 any salt of a derivative of barbituric acid or thiobarbituric
1007 acid, including, but not limited to, butabarbital and
1008 butalbital.
997 a. Alfentanil, as described in s. 893.03(2)(b)1.;
998 b. Carfentanil, as described in s. 893.03(2)(b)6.;
999 c. Fentanyl, as described in s. 893.03(2)(b)9.;
1000 d. Sufentanil, as described in s. 893.03(2)(b)30.;
1001 e. A fentanyl derivative, as described in s.
1002 893.03(1)(a)63.;
10091003 2f. Benzphetamine.
1010 3. Buprenorphine.
1011 4. Chlorhexadol.
1012 5. Chlorphentermine.
1013 6. Clortermine.
1014 7. Embutramide.
1015 8. Lysergic acid.
1016 9. Lysergic acid amide.
1017 10. Methyprylon.
1018 11. Perampanel.
1019 12. Phendimetrazine.
1020 13. Sulfondiethylmethane.
1021 14. Sulfonethylmethane.
1022 15. Sulfonmethane.
1023 16. Tiletamine and zolazepam or any salt thereof.
1024
17.
Xylazine
,
except for any drug product approved by the
1025
United States Food and Drug Administration which contains
1026
xylazine or a compounded form of xylazine labeled for veterinary
1027
use
,
which product is
prescribed or dispensed by a veterinarian
1028
licensed under
chapter
474
or labeled and dispensed
by a
1029
veterinarian licensed under chapter 474 or a pharmacy registered
1030
in this state pursuant to a prescription from a veterinarian
1031
licensed under chapter 474 who possesses xylazine for:
1032
a.
A
n animal owned by or under
a
veterinarian
’s care
. As
1033
used in this sub-
subparagraph, the term “
veterinarian
” includes
1034
a government agency or business where animals are located, and
1035
an employee or agent of an agency or business acting within the
1036
scope of their employment or agency.
1037
b.
U
se in government
al
animal-control programs authorized
1038
under applicable
f
ederal
,
s
tate
,
local
, or tribal
law
.
1039
c.
U
se in wildlife programs authorized under applicable
1040
f
ederal
,
s
tate
,
local
, or tribal
law
.
1041 Section 2. Paragraph (i) of subsection (1) of section
1042 893.13, Florida Statutes, is amended to read:
1043 893.13 Prohibited acts; penalties.—
1044 (1)
1045 (i) Except as authorized by this chapter, a person commits
1046 a felony of the first degree, punishable as provided in s.
1047 775.082, s. 775.083, or s. 775.084, and must be sentenced to a
1048 mandatory minimum term of imprisonment of 3 years, if:
1049 1. The person sells, manufactures, or delivers, or
1050 possesses with intent to sell, manufacture, or deliver, any of
1051 the following:
1052 a. Alfentanil, as described in s. 893.03(2)(b)1.;
1053 b. Carfentanil, as described in s. 893.03(2)(b)6.;
1054 c. Fentanyl, as described in s. 893.03(2)(b)9.;
1055 d. Sufentanil, as described in s. 893.03(2)(b)30.;
1056 e. A fentanyl derivative, as described in s.
1057 893.03(1)(a)63.;
1058 f.
Xylazine, as described in s. 893.03(1)(c)37.;
10591004
g.
A controlled substance analog, as described in s.
10601005 893.0356, of any substance described in
sub-subparagraphs a.-
f
.
10611006
sub-subparagraphs a.-e.
; or
10621007
h.
g.
A mixture containing any substance described in
sub
10631008
subparagraphs a.-g.
sub-subparagraphs a.-f.
; and
10641009 2. The substance or mixture listed in subparagraph 1. is in
10651010 a form that resembles, or is mixed, granulated, absorbed, spray
10661011 dried, or aerosolized as or onto, coated on, in whole or in
10671012 part, or solubilized with or into, a product, when such product
10681013 or its packaging further has at least one of the following
10691014 attributes:
10701015 a. Resembles the trade dress of a branded food product,
10711016 consumer food product, or logo food product;
10721017 b. Incorporates an actual or fake registered copyright,
10731018 service mark, or trademark;
10741019 c. Resembles candy, cereal, a gummy, a vitamin, or a
10751020 chewable product, such as a gum or gelatin-based product; or
10761021 d. Contains a cartoon character imprint.
10771022 Section 3. Paragraph (c) of subsection (1) of section
10781023 893.135, Florida Statutes, is amended to read:
10791024 893.135 Trafficking; mandatory sentences; suspension or
10801025 reduction of sentences; conspiracy to engage in trafficking.—
10811026 (1) Except as authorized in this chapter or in chapter 499
10821027 and notwithstanding the provisions of s. 893.13:
10831028 (c)1. A person who knowingly sells, purchases,
10841029 manufactures, delivers, or brings into this state, or who is
10851030 knowingly in actual or constructive possession of, 4 grams or
10861031 more of any morphine, opium, hydromorphone, or any salt,
10871032 derivative, isomer, or salt of an isomer thereof, including
10881033 heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or
10891034 (3)(c)4., or 4 grams or more of any mixture containing any such
10901035 substance, but less than 30 kilograms of such substance or
10911036 mixture, commits a felony of the first degree, which felony
10921037 shall be known as “trafficking in illegal drugs,” punishable as
10931038 provided in s. 775.082, s. 775.083, or s. 775.084. If the
10941039 quantity involved:
10951040 a. Is 4 grams or more, but less than 14 grams, such person
10961041 shall be sentenced to a mandatory minimum term of imprisonment
10971042 of 3 years and shall be ordered to pay a fine of $50,000.
10981043 b. Is 14 grams or more, but less than 28 grams, such person
10991044 shall be sentenced to a mandatory minimum term of imprisonment
11001045 of 15 years and shall be ordered to pay a fine of $100,000.
11011046 c. Is 28 grams or more, but less than 30 kilograms, such
11021047 person shall be sentenced to a mandatory minimum term of
11031048 imprisonment of 25 years and shall be ordered to pay a fine of
11041049 $500,000.
11051050 2. A person who knowingly sells, purchases, manufactures,
11061051 delivers, or brings into this state, or who is knowingly in
11071052 actual or constructive possession of, 28 grams or more of
11081053 hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as
11091054 described in s. 893.03(2)(a)1.g., or any salt thereof, or 28
11101055 grams or more of any mixture containing any such substance,
11111056 commits a felony of the first degree, which felony shall be
11121057 known as “trafficking in hydrocodone,” punishable as provided in
11131058 s. 775.082, s. 775.083, or s. 775.084. If the quantity involved:
11141059 a. Is 28 grams or more, but less than 50 grams, such person
11151060 shall be sentenced to a mandatory minimum term of imprisonment
11161061 of 3 years and shall be ordered to pay a fine of $50,000.
11171062 b. Is 50 grams or more, but less than 100 grams, such
11181063 person shall be sentenced to a mandatory minimum term of
11191064 imprisonment of 7 years and shall be ordered to pay a fine of
11201065 $100,000.
11211066 c. Is 100 grams or more, but less than 300 grams, such
1067 person shall be sentenced to a mandatory minimum term of
1068 imprisonment of 15 years and shall be ordered to pay a fine of
1069 $500,000.
1070 d. Is 300 grams or more, but less than 30 kilograms, such
11221071 person shall be sentenced to a mandatory minimum term of
11231072 imprisonment of 1525 years and shall be ordered to pay a fine of
11241073 $500750,000.
1074 3. A person who knowingly sells, purchases, manufactures,
1075 delivers, or brings into this state, or who is knowingly in
1076 actual or constructive possession of, 7 grams or more of
1077 oxycodone, as described in s. 893.03(2)(a)1.q., or any salt
1125 d. Is1078 thereof, 300or 7 grams or more, butof lessany thanmixture 30containing kilograms,any such
1079 substance, commits a felony of the first degree, which felony
1080 shall be known as “trafficking in oxycodone,” punishable as
1081 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1082 quantity involved:
1083 a. Is 7 grams or more, but less than 14 grams, such person
11261084 person shall be sentenced to a mandatory minimum term of imprisonment
1085 of 3 years and shall be ordered to pay a fine of $50,000.
1086 b. Is 14 grams or more, but less than 25 grams, such person
1087 shall be sentenced to a mandatory minimum term of imprisonment
1088 of 7 years and shall be ordered to pay a fine of $100,000.
1089 c. Is 25 grams or more, but less than 100 grams, such
1090 person shall be sentenced to a mandatory minimum term of
11271091 imprisonment of 2515 years and shall be ordered to pay a fine of
11281092 $750500,000.
1093 d. Is 100 grams or more, but less than 30 kilograms, such
1094 person shall be sentenced to a mandatory minimum term of
1095 imprisonment of 25 years and shall be ordered to pay a fine of
1096 $750,000.
11291097 34.a. A person who knowingly sells, purchases, manufactures,
11301098 delivers, or brings into this state, or who is knowingly in
11311099 actual or constructive possession of, 74 grams or more of:
1132 oxycodone1100 (I) Alfentanil, as described in s. 893.03(2)(ab)1.q., or any salt;
1133 thereof, or 7 grams or more of any mixture containing any such
1134 substance, commits a felony of the first degree, which felony
1135 shall be known as “trafficking in oxycodone,” punishable as
1136 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1137 quantity involved:
1138 a. Is 7 grams or more, but less than 14 grams, such person
1139 shall be sentenced to a mandatory minimum term of imprisonment
1140 of 3 years and shall be ordered to pay a fine of $50,000.
1141 b. Is 14 grams or more, but less than 25 grams, such person
1142 shall be sentenced to a mandatory minimum term of imprisonment
1143 of 7 years and shall be ordered to pay a fine of $100,000.
1144 c. Is 25 grams or more, but less than 100 grams, such
1145 person shall be sentenced to a mandatory minimum term of
1146 imprisonment of 15 years and shall be ordered to pay a fine of
1147 $500,000.
1148 d. Is 100 grams or more, but less than 30 kilograms, such
1149 person shall be sentenced to a mandatory minimum term of
1150 imprisonment of 25 years and shall be ordered to pay a fine of
1151 $750,000.
1152 4.a. A person who knowingly sells, purchases, manufactures,
1153 delivers, or brings into this state, or who is knowingly in
1154 actual or constructive possession of, 4 grams or more of:
11551101 (III) AlfentanilCarfentanil, as described in s. 893.03(2)(b)16.;
1102 (III) Fentanyl, as described in s. 893.03(2)(b)9.;
11561103 (IIIV) CarfentanilSufentanil, as described in s. 893.03(2)(b)630.;
11571104 (IIIV) FentanylA fentanyl derivative, as described in s. 893.03(2)(b)9.;
1105 893.03(1)(a)63.;
1106 (VI) A controlled substance analog, as described in s.
1107 893.0356, of any substance described in sub-sub-subparagraphs
1108 (I)-(V); or
11581109 (IVVII) Sufentanil,A asmixture containing any substance described in s. 893.03(2)(b)30.;sub
1159 (V) A fentanyl derivative, as described in s.
1160 893.03(1)(a)63.;
1161 (VI) A controlled substance analog, as described in s.
1110 sub-subparagraphs (I)-(VI),
1111
1112 commits a felony of the first degree, which felony shall be
1113 known as “trafficking in dangerous fentanyl or fentanyl
1114 analogues,” punishable as provided in s. 775.082, s. 775.083, or
1115 s. 775.084.
1162 8931116 b.0356, If ofthe anyquantity substanceinvolved describedunder insub-subparagraph sub-sub-subparagraphsa.:
1163 (I)-(V); or
1164 (VII) A mixture containing any substance described in sub
1165 sub-subparagraphs (I)-(VI),
1166
1167 commits a felony of the first degree, which felony shall be
1168 known as “trafficking in dangerous fentanyl or fentanyl
1169 analogues,” punishable as provided in s. 775.082, s. 775.083, or
1170 s. 775.084.
1171 b. If the quantity involved under sub-subparagraph a.:
11721117 (I) Is 4 grams or more, but less than 14 grams, such person
11731118 shall be sentenced to a mandatory minimum term of imprisonment
11741119 of 7 years
,
and shall be ordered to pay a fine of $50,000.
11751120 (II) Is 14 grams or more, but less than 28 grams, such
11761121 person shall be sentenced to a mandatory minimum term of
11771122 imprisonment of 20 years
,
and shall be ordered to pay a fine of
11781123 $100,000.
11791124 (III) Is 28 grams or more, such person shall be sentenced
11801125 to a mandatory minimum term of imprisonment of 25 years
,
and
11811126 shall be ordered to pay a fine of $500,000.
11821127 c. A person 18 years of age or older who violates sub
11831128 subparagraph a. by knowingly selling or delivering to a minor at
11841129 least 4 grams of a substance or mixture listed in sub
11851130 subparagraph a. shall be sentenced to a mandatory minimum term
11861131 of not less than 25 years and not exceeding life imprisonment,
11871132 and shall be ordered to pay a fine of $1 million if the
11881133 substance or mixture listed in sub-subparagraph a. is in a form
11891134 that resembles, or is mixed, granulated, absorbed, spray-dried,
11901135 or aerosolized as or onto, coated on, in whole or in part, or
11911136 solubilized with or into, a product, when such product or its
11921137 packaging further has at least one of the following attributes:
11931138 (I) Resembles the trade dress of a branded food product,
11941139 consumer food product, or logo food product;
11951140 (II) Incorporates an actual or fake registered copyright,
11961141 service mark, or trademark;
11971142 (III) Resembles candy, cereal, a gummy, a vitamin, or a
11981143 chewable product, such as a gum or gelatin-based product; or
11991144 (IV) Contains a cartoon character imprint.
12001145 5. A person who knowingly sells, purchases, manufactures,
12011146 delivers, or brings into this state, or who is knowingly in
12021147 actual or constructive possession of, 30 kilograms or more of
12031148 any morphine, opium, oxycodone, hydrocodone, codeine,
12041149 hydromorphone, or any salt, derivative, isomer, or salt of an
12051150 isomer thereof, including heroin, as described in s.
12061151 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or
12071152 more of any mixture containing any such substance, commits the
12081153 first degree felony of trafficking in illegal drugs. A person
12091154 who has been convicted of the first degree felony of trafficking
12101155 in illegal drugs under this subparagraph shall be punished by
12111156 life imprisonment and is ineligible for any form of
12121157 discretionary early release except pardon or executive clemency
12131158 or conditional medical release under s. 947.149. However, if the
12141159 court determines that, in addition to committing any act
12151160 specified in this paragraph:
12161161 a. The person intentionally killed an individual or
12171162 counseled, commanded, induced, procured, or caused the
12181163 intentional killing of an individual and such killing was the
12191164 result; or
12201165 b. The person’s conduct in committing that act led to a
12211166 natural, though not inevitable, lethal result,
1222
1167
12231168 such person commits the capital felony of trafficking in illegal
12241169 drugs, punishable as provided in ss. 775.082 and 921.142. A
12251170 person sentenced for a capital felony under this paragraph shall
12261171 also be sentenced to pay the maximum fine provided under
12271172 subparagraph 1.
12281173 6. A person who knowingly brings into this state 60
12291174 kilograms or more of any morphine, opium, oxycodone,
12301175 hydrocodone, codeine, hydromorphone, or any salt, derivative,
12311176 isomer, or salt of an isomer thereof, including heroin, as
12321177 described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or
12331178 60 kilograms or more of any mixture containing any such
12341179 substance, and who knows that the probable result of such
12351180 importation would be the death of a person, commits capital
12361181 importation of illegal drugs, a capital felony punishable as
12371182 provided in ss. 775.082 and 921.142. A person sentenced for a
12381183 capital felony under this paragraph shall also be sentenced to
12391184 pay the maximum fine provided under subparagraph 1.
1240
1185
7.
A person who knowingly sells, purchases, manufactures,
12411186
delivers, or brings into this state, or who is knowingly in
1242
1187
actual or constructive possession of, 4 grams or more of
1243
1188
xylazine, as described in s. 893.03(1)(c)37., or any salt
1244
1189
thereof, or 4 grams or more of any mixture containing any such
1245
1190
substance, commits a felony of the first degree, which felony
1246
1191
shall be known as “trafficking in xylazine,” punishable as
12471192
provided in s. 775.082, s. 775.083, or s. 775.084. If the
1248
1193
quantity involved:
12491194
a.
Is 4 grams or more, but less than 14 grams, such person
12501195
shall be sentenced to a mandatory minimum term of imprisonment
12511196
of 7 years and shall be ordered to pay a fine of $50,000.
1252
1197
b.
Is 14 grams or more, but less than 28 grams, such person
1253
1198
shall be sentenced to a mandatory minimum term of imprisonment
1254
1199
of 20 years and shall be ordered to pay a fine of $100,000.
12551200
c.
Is 28 grams or more, such person shall be sentenced to a
12561201
mandatory minimum term of imprisonment of 25 years and shall be
12571202
ordered to pay a fine of $500,000.
12581203 Section 4. This act shall take effect October 1, 2025.